NFKB1 and lymphoma: The calibration dataset contained additional independent validation samples (not used for calibration): healthy memory and naïve B cells were correctly scored as NFκB pathway inactive, while follicular and DBLCL1 lymphomas and lymphoma cell lines showed expected high NFκB pathway activity (Fig. 4B)37–39.